Fig. 3From: The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancerOverall survival according to the combination of the pretreatment and posttreatment C-reactive protein to albumin (CRP/ALB) ratio values. The prognosis of the patients in group B tended to be better than that in the patients of group C (p = 0.0641)Back to article page